http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010507571-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G83-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6524 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate | 2007-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010507571-A |
| titleOfInvention | Dendritic chelate compound, method for producing the compound, and pharmaceutical composition containing the compound |
| abstract | The present invention relates to a dendritic chelate compound, a method for producing the compound, and a pharmaceutical composition containing the compound. Dendritic chelate complexes of the present invention have the formula I: [[MC] -E n - [D] m -X 1p1 X 2p2 X 3p3 X 4p4] z - zB + (I). Where M is a magnetic or scintigraphic marker, C is a chelating agent for magnetic marker M, E is a spacer, n = 0 or 1, and D is a compound capable of forming a dendritic structure. M is an integer equal to 1 or 2 or 4, X 1 is a group that increases the lipophilicity of the complex, p 1 is an integer from 0 to 12, and X 2 is the specificity of the complex for a particular organ A group that increases sex, p2 is an integer equal to 0, 1, 2 or 4; X 3 is a group having therapeutic activity; p3 is an integer equal to 0, 1, 2 or 4; 4 is a CH 3 group, p4 is an integer from 0 to 12, B is a counter ion, and z is an integer equal to 0, 1, 2, 3 or 4. The present invention can be used in the field of pharmacy, more precisely for medical imaging. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013537883-A |
| priorityDate | 2006-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.